SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001654954-23-015080
Filing Date
2023-12-01
Accepted
2023-12-01 16:47:54
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-1 tenx_s1.htm S-1 695521
2 CONSENT OF INDEPENDENT tenx_ex231.htm EX-23.1 2342
3 FEE TABLE tenx_ex107.htm EX-FILING FEES 23783
4 tenx_s1img3.jpg GRAPHIC 6869
5 tenx_s1img4.jpg GRAPHIC 10381
  Complete submission text file 0001654954-23-015080.txt   746945
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-275856 | Film No.: 231460223
SIC: 2834 Pharmaceutical Preparations